Open AccessUsing of multi-kinase inhibitor regorafenib for metastatic colorectal cancer
Author(s) -
Oleg I. Kit,
Кит О И,
Liubov Yu Vladimirova,
Л. Ю. Владимирова,
Natalya A Abramova,
Natalia А. Abramova,
Anna E. Storozhakova,
Anna E. Storozhakova,
Irina L. Popova,
Irina L. Popova,
N. M. Tikhanovskaya,
Н. М. Тихановская,
A A Lyaynova,
А. А. Льянова,
Ludmila A. Ryadinskaya,
Л. А. Рядинская
Publication year - 2017
Publication title -
sovremennaâ onkologiâ
Language(s) - English
Resource type - Journals
eISSN - 1815-1442
pISSN - 1815-1434
DOI - 10.26442/1815-1434_19.2.42-46
Subject(s) - regorafenib , medicine , colorectal cancer , vomiting , nausea , adverse effect , refractory (planetary science) , oncology , gastroenterology , combination therapy , chemotherapy , diarrhea , toxicity , cancer , physics , astrobiology